This article was originally published in The Tan Sheet
PowerBar plant closing; Medifast, investor agree on board changes; BioPharmX announces IPO; Mérieux expands southeast U.S. testing; more news in brief.
You may also be interested in...
The trade group Global Organization for EPA and DHA Omega-3 petitions FDA for an unqualified health claim related to reduced blood pressure as a surrogate marker for coronary heart disease risk.
FDA finalizes OTC dosing guidance
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.